ALAFOSS-01
Phase 1 Terminated
17 enrolled
HAITI
Phase 2 Terminated
4 enrolled
A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Phase 1 Terminated
128 enrolled
Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma
Phase 2 Terminated
4 enrolled 11 charts
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
Phase 2 Terminated
59 enrolled 18 charts
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
ZN-c3 in Adult Participants With Metastatic Colorectal Cancer
Phase 1 Terminated
44 enrolled
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
Phase 1/2 Terminated
125 enrolled
A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer
Phase 2 Terminated
16 enrolled 29 charts
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors
Phase 1/2 Terminated
5 enrolled 9 charts
XXL_2022-01
Phase 3 Terminated
19 enrolled
APK Mutant
Phase 2 Terminated
7 enrolled 15 charts
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Phase 3 Terminated
340 enrolled
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Phase 1/2 Terminated
2 enrolled 13 charts
PF-07284892 in Participants With Advanced Solid Tumors
Phase 1 Terminated
53 enrolled
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
Phase 1 Terminated
206 enrolled
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Phase 1 Terminated
5 enrolled
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
1,333 enrolled 22 charts
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Phase 2 Terminated
30 enrolled 17 charts
Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)
Phase 2 Terminated
3 enrolled 6 charts
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
Phase 1/2 Terminated
13 enrolled 6 charts
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
Phase 2 Terminated
3 enrolled
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
Phase 2 Terminated
23 enrolled 8 charts
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Phase 1/2 Terminated
5 enrolled 9 charts
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase 1 Terminated
11 enrolled
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
Phase 1 Terminated
4 enrolled
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
Phase NA Terminated
8 enrolled 9 charts
IMPACT-CRC
Phase 1/2 Terminated
85 enrolled
COPAN-ORL06
Phase 1/2 Terminated
11 enrolled
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
EXTAX
Phase 2 Terminated
17 enrolled 8 charts
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer
Phase 2 Terminated
7 enrolled 5 charts
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Phase 4 Terminated
4 enrolled
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Phase 2 Terminated
50 enrolled 9 charts
MK-0646-025
Phase 2 Terminated
11 enrolled 8 charts
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Phase 1/2 Terminated
3 enrolled 7 charts
SKINUX
Phase NA Terminated
25 enrolled
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
Phase 2 Terminated
19 enrolled
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
Phase 2 Terminated
6 enrolled 7 charts
A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab
Phase 1 Terminated
18 enrolled
PembroMab
Phase 1/2 Terminated
16 enrolled 6 charts
Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery
Phase 2 Terminated
8 enrolled 16 charts
A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
Phase 1 Terminated
15 enrolled
Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy
Phase 1 Terminated
13 enrolled
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Phase 2 Terminated
13 enrolled 9 charts
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Phase 2 Terminated
19 enrolled 32 charts
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
Phase 2 Terminated
87 enrolled 13 charts
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
Phase 2 Terminated
249 enrolled 4 charts
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
Phase 1/2 Terminated
15 enrolled 11 charts